Cargando…

Prognostic Role of Molecular and Imaging Biomarkers for Predicting Advanced Hepatocellular Carcinoma Treatment Efficacy

SIMPLE SUMMARY: Molecular biomarkers play a marginal role in clinical practice for hepatocellular carcinoma (HCC) diagnosis, surveillance and treatment monitoring. Radiological biomarker: alpha-fetoprotein is still a lone protagonist in this field. The potential role of molecular biomarkers in the a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cerrito, Lucia, Ainora, Maria Elena, Mosoni, Carolina, Borriello, Raffaele, Gasbarrini, Antonio, Zocco, Maria Assunta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9564154/ https://www.ncbi.nlm.nih.gov/pubmed/36230569 http://dx.doi.org/10.3390/cancers14194647

Ejemplares similares

Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease: The Prognostic Role of Liver Stiffness Measurement
por: Cerrito, Lucia, et al.
Publicado: (2023)

The Role of Contrast-Enhanced Ultrasound (CEUS) in the Detection of Neoplastic Portal Vein Thrombosis in Patients with Hepatocellular Carcinoma
por: Cerrito, Lucia, et al.
Publicado: (2023)

Contrast-Enhanced Imaging in the Management of Intrahepatic Cholangiocarcinoma: State of Art and Future Perspectives
por: Cerrito, Lucia, et al.
Publicado: (2023)

Contrast-Enhanced Ultrasound for Monitoring Treatment Response in Different Stages of Hepatocellular Carcinoma
por: Faccia, Mariella, et al.
Publicado: (2022)

Elastography as a predictor of liver cirrhosis complications after hepatitis C virus eradication in the era of direct-acting antivirals
por: Cerrito, Lucia, et al.
Publicado: (2021)

Dynamic contrast enhanced ultrasound in gastrointestinal diseases: A current trend or an indispensable tool?
por: Paratore, Mattia, et al.
Publicado: (2023)

Tumorigenesis in Inflammatory Bowel Disease: Microbiota-Environment Interconnections
por: Mignini, Irene, et al.
Publicado: (2023)

Role of Multiparametric Intestinal Ultrasound in the Evaluation of Response to Biologic Therapy in Adults with Crohn’s Disease
por: Puca, Pierluigi, et al.
Publicado: (2022)

Shear Wave Dispersion in Chronic Liver Disease: From Physical Principles to Clinical Usefulness
por: Garcovich, Matteo, et al.
Publicado: (2023)

Ultrasound Elastography to Assess Age of Deep Vein Thrombosis: A Systematic Review
por: Santini, Paolo, et al.
Publicado: (2023)

Predicting Treatment Response in Inflammatory Bowel Diseases: Cross-Sectional Imaging Markers
por: Mignini, Irene, et al.
Publicado: (2023)

Diagnostic and Prognostic Role of Extracellular Vesicles in Pancreatic Cancer: Current Evidence and Future Perspectives
por: Nicoletti, Alberto, et al.
Publicado: (2023)

Correlation between a New Point-Shear Wave Elastography Device (X+pSWE) with Liver Histology and 2D-SWE (SSI) for Liver Stiffness Quantification in Chronic Liver Disease
por: Garcovich, Matteo, et al.
Publicado: (2023)

Portal vein thrombosis in cirrhosis: Why a well-known complication is still matter of debate
por: Faccia, Mariella, et al.
Publicado: (2019)

Endoscopic Ultrasound-Guided Locoregional Treatments for Solid Pancreatic Neoplasms
por: Di Gialleonardo, Luca, et al.
Publicado: (2023)

Multiparametric Dynamic Ultrasound Approach for Differential Diagnosis of Primary Liver Tumors
por: Ainora, Maria Elena, et al.
Publicado: (2023)

The Role of Transabdominal Ultrasound Elastography in Gastrointestinal Non-Liver Diseases: Current Application and Future Prospectives
por: Paratore, Mattia, et al.
Publicado: (2023)

Minimal Hepatic Encephalopathy is Associated with Increased Cerebral Vascular Resistance. A Transcranial Doppler Ultrasound Study
por: Ponziani, Francesca Romana, et al.
Publicado: (2019)

Eubiotic properties of rifaximin: Disruption of the traditional concepts in gut microbiota modulation
por: Ponziani, Francesca Romana, et al.
Publicado: (2017)

Risk factors for portal vein thrombosis or venous thromboembolism in a large cohort of hospitalized cirrhotic patients
por: Faccia, Mariella, et al.
Publicado: (2022)

Subclinical atherosclerosis is linked to small intestinal bacterial overgrowth via vitamin K2-dependent mechanisms
por: Ponziani, Francesca Romana, et al.
Publicado: (2017)

Chemotherapy for Hepatocellular Carcinoma: Current Evidence and Future Perspectives
por: Rinninella, Emanuele, et al.
Publicado: (2017)

An undetectable source of recurrent gastrointestinal bleeding: hemosuccus pancreaticus
por: Borriello, Raffaele, et al.
Publicado: (2023)

Impact of Lactobacillus reuteri Supplementation on Anti-Helicobacter pylori Levofloxacin-Based Second-Line Therapy
por: Ojetti, Veronica, et al.
Publicado: (2012)

The New Era of Systemic Treatment for Hepatocellular Carcinoma: From the First Line to the Optimal Sequence
por: Cerreto, Maria, et al.
Publicado: (2023)

Future of liver disease in the era of direct acting antivirals for the treatment of hepatitis C
por: Ponziani, Francesca Romana, et al.
Publicado: (2017)

Reverse time-dependent effect of alphafetoprotein and disease control on survival of patients with Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma
por: Ponziani, Francesca Romana, et al.
Publicado: (2017)

Treatment of hepatocellular carcinoma in patients with portal vein tumor thrombosis: Beyond the known frontiers
por: Cerrito, Lucia, et al.
Publicado: (2019)

The Role of Gut Microbiota in Heart Failure: When Friends Become Enemies
por: Cianci, Rossella, et al.
Publicado: (2022)

Immunological inflammatory biomarkers as prognostic predictors for advanced hepatocellular carcinoma
por: Nakano, M., et al.
Publicado: (2021)

Non-Invasive Biomarkers for Immunotherapy in Patients with Hepatocellular Carcinoma: Current Knowledge and Future Perspectives
por: Pallozzi, Maria, et al.
Publicado: (2022)

Molecular Landscape and Prognostic Biomarker Analysis of Advanced Pancreatic Cancer and Predictors of Treatment Efficacy of AG Chemotherapy
por: Du, Juan, et al.
Publicado: (2022)

Prognostic value of the neutrophil-to-lymphocyte ratio in the ARQ 197-215 second-line study for advanced hepatocellular carcinoma
por: Personeni, Nicola, et al.
Publicado: (2017)

Contrast-enhanced ultrasound Liver Imaging Reporting and Data System: Lights and shadows in hepatocellular carcinoma and cholangiocellular carcinoma diagnosis
por: Vidili, Gianpaolo, et al.
Publicado: (2022)

Baclofen for the Treatment of Alcohol Use Disorder in Patients With Liver Cirrhosis: 10 Years After the First Evidence
por: Mosoni, Carolina, et al.
Publicado: (2018)

Factors Influencing Microbiota in Modulating Vaccine Immune Response: A Long Way to Go
por: Ponziani, Francesca Romana, et al.
Publicado: (2023)

The Interplay between Immunosenescence and Microbiota in the Efficacy of Vaccines
por: Cianci, Rossella, et al.
Publicado: (2020)

Molecular and Clinical Features of Hepatocellular Carcinoma in Patients with HBV-HDV Infection
por: Costante, Federico, et al.
Publicado: (2023)

ASF1B is a Promising Prognostic Biomarker and Correlates With Immunotherapy Efficacy in Hepatocellular Carcinoma
por: Zhang, Shirong, et al.
Publicado: (2022)

Viral hepatitis and hepatocellular carcinoma: From molecular pathways to the role of clinical surveillance and antiviral treatment
por: Stella, Leonardo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hoe0uuedom0fk69uta3uietfvh